Optimise your PCR-based testing infrastructure to meet current and future infectious disease detection needs.
Your partner for every pivot
Scale with ease as needs change.The onset of the COVID-19 global pandemic in early 2020 marked the start of a dramatic pivot in clinical diagnostic assay development, and in patient sample collection and processing. As vaccination programmes roll out, diagnostic assay developers and testing labs need to remain vigilant in accommodating the evolving needs of the public health crisis as well as ongoing demand for patient screening for a wide breadth of conditions.
Throughout the COVID-19 pandemic, Biosearch Technologies demonstrated a unique ability to serve the diagnostic community as a reliable mission-critical component supplier. Explore how we can help your organisation manage today while planning for tomorrow.
Plan ahead to see how you can expand services as demands for PCR-based pathogen detection evolve.
Develop your game plan for In Vitro Diagnostic Regulation (IVDR) compliance.
Customise our solutions to meet your specificationsWe have the expertise to leverage our flexible manufacturing platform to deliver according to your specifications and throughput, yielding a product that produces repeatable and consistent performance. Our comprehensive portfolio grants our customers unparalleled freedom for customisation that’s coupled with a hands-on team to help bring your ideas and aspirations to life.
Think success at scale right from the start
6 tips for early-stage molecular diagnostics companies to commercialise.
Find vendors who can be partners
What to look for in a reliable molecular diagnostic supplier
How our oligo synthesis team contributes to the reliability of your assays.